(Q37614697)

English

Positron emission tomography measurement of brain MAO-B inhibition in patients with Alzheimer's disease and elderly controls after oral administration of sembragiline

scientific article published on 16 September 2016

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Positron emission tomography measurement of brain MAO-B inhibition in patients with Alzheimer's disease and elderly controls after oral administration of sembragiline (English)

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Alzheimer's disease

0 references

positron emission tomography

1 reference

based on heuristic

inferred from title

object named as

Patrik Fazio

8

0 references

object named as

Anton Forsberg

2

0 references

Christer Halldin

14

object named as

Christer Halldin

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

author name string

Stefan Sturm

1

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Stephane Nave

3

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Per Stenkrona

4

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Nicholas Seneca

5

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Andrea Varrone

6

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Robert A Comley

7

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Candice Jamois

9

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Ryuji Nakao

10

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Zbigniew Ejduk

11

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Nabil Al-Tawil

12

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Ulrika Akenine

13

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Niels Andreasen

15

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Benedicte Ricci

16

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

16 September 2016

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

number of pages

10

1 reference

based on heuristic

inferred from page(s)

European Journal of Nuclear Medicine and Molecular Imaging

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

44

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

3

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

382-391

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

copyright license

Creative Commons Attribution 4.0 International

16 September 2016

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

https://scigraph.springernature.com/pub.10.1007/s00259-016-3510-6

0 references

The role of dopamine in symptoms and treatment of apathy in Alzheimer's disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5281649

23 August 2017

Serotonin receptors represent highly favorable molecular targets for cognitive enhancement in schizophrenia and other disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5281649

23 August 2017

Monoamine oxidase-B inhibition in Alzheimer's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5281649

23 August 2017

Monoamine oxidase and cigarette smoking.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5281649

23 August 2017

Selegiline for Alzheimer's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5281649

23 August 2017

Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5281649

23 August 2017

Increased monoamine oxidase B activity in plaque-associated astrocytes of Alzheimer brains revealed by quantitative enzyme radioautography

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5281649

23 August 2017

Monoamine oxidase, brain ageing and degenerative diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5281649

6 September 2017

Evidence for astrocytosis in prodromal Alzheimer disease provided by 11C-deuterium-L-deprenyl: a multitracer PET paradigm combining 11C-Pittsburgh compound B and 18F-FDG.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5281649

14 September 2017

A selective reversible monoamine oxidase B inhibitor in smoking cessation: effects on its own and in association with transdermal nicotine patch

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5281649

25 June 2018

Biphasic and region-specific MAO-B response to aging in normal human brain.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5281649

25 June 2018

Improved synthesis of some commonly used PET radioligands by the use of [11C]methyl triflate.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5281649

25 June 2018

Dopaminergic system and monoamine oxidase-B activity in Alzheimer's disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5281649

25 June 2018

Expression of monoamine oxidase B activity in astrocytes of senile plaques.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5281649

25 June 2018

Assessment of MAO-B occupancy in the brain with PET and [11C]-L-deprenyl-D2: a dose-finding study with a novel MAO-B inhibitor, EVT 301.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5281649

1 September 2018

Early and persistent alterations in prefrontal cortex MAO A and B in Alzheimer's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5281649

1 September 2018

Reproducibility of repeated measures of deuterium substituted [11C]L-deprenyl ([11C]L-deprenyl-D2) binding in the human brain.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5281649

1 September 2018

Age-related increases in brain monoamine oxidase B in living healthy human subjects.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5281649

1 September 2018

A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5281649

1 September 2018

The ECAT EXACT HR: performance of a new high resolution positron scanner.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5281649

1 September 2018

Measurement of human cerebral monoamine oxidase type B (MAO-B) activity with positron emission tomography (PET): a dose ranging study with the reversible inhibitor Ro 19-6327

1 reference

https://api.crossref.org/works/10.1007%2FS00259-016-3510-6

21 January 2018

Mapping human brain monoamine oxidase A and B with 11C-labeled suicide inactivators and PET

1 reference

https://pubmed.ncbi.nlm.nih.gov/27633250

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Slow recovery of human brain MAO B after L-deprenyl (Selegeline) withdrawal

1 reference

https://pubmed.ncbi.nlm.nih.gov/27633250

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selective reduction of radiotracer trapping by deuterium substitution: comparison of carbon-11-L-deprenyl and carbon-11-deprenyl-D2 for MAO B mapping

1 reference

https://pubmed.ncbi.nlm.nih.gov/27633250

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00259-016-3510-6

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

21 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37614697&oldid=1850714199"